Browsing by Author Pongsatha S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 37  next >
Issue DateTitleAuthor(s)
2009Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: A cross sectional studyPongsatha S.; Ekmahachai M.; Chaovisitsaree S.; Suntornlimsiri N.; Morakote N.
2010Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 yearsPongsatha S.; Ekmahachai M.; Suntornlimsiri N.; Morakote N.; Chaovisitsaree S.
2001A comparison between 50 mcg oral misoprostol every 4 hours and 6 hours for labor induction: A prospective randomized controlled trialPongsatha S.; Tongsong T.; Somsak T.
2002A comparison of 100 microg oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trialPongsatha S.; Sirisukkasem S.; Tongsong T.
2002A comparison of 100 μg oral misoprostol every 3 hours and 6 hours for labor induction: A randomized controlled trialPongsatha S.; Sirisukkasem S.; Tongsong T.
2005A comparison of labor induction by oral and vaginal misoprostolPongsatha S.; Vijittrawiwat A.; Tongsong T.
2002Demographic characteristics of women with self use of misoprostol for pregnancy interruption attending Maharaj Nakorn Chiang Mai HospitalPongsatha S.; Morakot N.; Tongsong T.
2000Early prenatal sonographic diagnosis of congenital hypophosphatasiaTongsong T.; Pongsatha S.
1999First-trimester diagnosis of conjoined twins: a report of three casesTongsong T.; Chanprapaph P.; Pongsatha S.
2013How to manage unresponsiveness to misoprostol in failed second trimester pregnancy terminationPongsatha S.; Tongsong T.
2004Immediate complications of laparoscopic tubal sterilization: 11 Years of experienceChaovisitsaree S.; Piyamongkol W.; Pongsatha S.; Kunaviktikul C.; Morakote N.; Chandarawong W.
2004Intravaginal misoprostol for pregnancy terminationPongsatha S.; Tongsong T.
2004Mammographic Change in Hysterectomized Women on 0.625 mg/day of Conjugated Equine EstrogenPanpanit A.; Pongsatha S.; Piyamongkol W.; Morakot N.; Noi-Um S.; Chuntaranikul M.; Muttarak M.; Chaovisitsaree S.; Truengthawatchai S.; Sribanditmongkol N.; Churith K.
2006Mammographic changes related to different types of hormonal therapiesPongsatha S.; Muttarak M.; Chaovisitseree S.; Luewan S.; Panpanit A.
3Menopause-related symptoms and quality of life in peri-and postmenopausal women in Thailand: A multicenter studyPanichkul S.; Wongwananuruk T.; Boonyanurak P.; Wiriyasirivaj B.; Wanichsetakul P.; Pongsatha S.; Peeyananjarassri K.; Amatyakul P.; Wipatavit V.; Kaewrudee S.; Limwattananon C.; Cheawchanwattana A.; Soontarapa S.; Wilawana K.; Rattanachaiyanont M.
2003Misoprostol for second trimester termination of pregnancies with prior low transverse cesarean sectionPongsatha S.; Tongsong T.
2005Morning and evening administration of hormone therapy in perimenopausal womenPongsatha S.; Chainual A.; Morakote N.
1999Omphalopagus conjoined twinsTongsong T.; Chanprapaph P.; Pongsatha S.
2005One year study of Implanon on the adverse events and discontinuationChaovisitsaree S.; Piyamongkol W.; Pongsatha S.; Morakote N.; Noium S.; Soonthornlimsiri N.
2011Outcomes of pregnancy termination by misoprostol at 14-32 weeks of gestation: A 10-year-experiencePongsatha S.; Tongsong T.